The tech behind the test

Pathology technology drives the provision of high quality, accessible and affordable healthcare services.

We represent the manufacturers and importers of technologies that enables pathology testing in laboratories, hospitals and the community.

PTA Congress


What We do

Pathology Technology Australia Ltd is the peak industry body representing manufacturers and importers of tests and technologies, vital to testing patient samples in the pathology laboratory, in hospitals and in the primary care setting. This technology enables more than 800 million tests to be perform in Australia every year.

Our members not only develop, manufacture and supply this technology, they also train doctors and scientists in its use, provide technical specialists to service it, constantly monitor and improve quality and maintain the supply chain. In effect, we make pathology possible.

Group 2
4855 LondonAgency-199
4855 LondonAgency-324

What are the benefits of Pathology Technology Australia



Membership is open to companies that supply or intend to supply tests, technology and consumables used in the diagnosis of disease or other health conditions; to cure, mitigate, treat, monitor or prevent disease or its sequelae. This includes technical services, IT and consulting; products for sample collection, preparation and examination; products used for in-house testing, companion diagnostics and in personalised medicine. Fees are based on the company turnover of these products in Australia


Events and Services

Members enjoy a range of events and services. Events include guest speaker engagement that cover a range of topics, a special AGM event each year where members get to meet senior industry stakeholders and our quarterly Executive Breakfast Meeting. Services include a weekly CEO Update, highlighting up-to-the-minute industry new, Podcasts and social media posts and this website – where members can obtain key resources. We also offer basic training in TGA and business compliance requirements. Our market data survey is a very popular service enjoyed by almost all members. See the Events page for the latest and for registering to attend an event.



We advocate on behalf of members in many key areas of business. Our relationship with the TGA is exceptional and we work on a weekly basis to contribute to guidance documents, consulting processes and on behalf of individual members. We work with and on behalf of members in MSAC applications for MBS funding. We work with the Commonwealth and state health departments and well as key politicians and Ministers. We have cultivated relationships with key business and consumer health groups. We are now well known by most of the mainstream media outlets and contribute regularly to TV, radio, print and online services.



We are a major supporter of the Know Pathology Know Healthcare program. This globally unique program is a consortium between public and private pathology service providers, professional bodies and the suppliers. It aims to raise the profile of pathology by holding events, through an informative website, via a monthly newsletter and holding lab tours for our elected politicians. We are also a member of the Continuity of Care Collaboration, a unique communication collaboration of over 35 peak bodies, industry and healthcare organisations coming together to stress the importance of people continuing with monitoring their health status. You can follow us on LinkedIn and Twitter with this handle @pathologytechnology, and via this website.

Message from our CEO – Dean Whiting

Latest News

APS (Antiphospholipid Syndrome)

10 Nov 2022

Our story is about a patient named April. April was diagnosed with APS (Antiphospholipid Syndrome) following her 39th birthday, after […]

Read More

Rapid Tests

04 Aug 2022

Recent commentary questioning the performance of rapid antigen tests (RATs) against subvariants of Omicron is dangerously misleading and risks undermining […]

Read More

TGA delays the IVDR Deadline to May 2023

13 Jun 2022

The European IVDR device registration changes impact IVDs manufactured in Europe. These changes bring medical device quality certification, registration into line with practices already adopted in other parts of the world (especially north America and Australia).

Read More
IVD064_Members Banner 2021 v4
Scroll to Top